Johnson & Johnson Medical Devices Rebrands as Johnson & Johnson MedTech to Drive Innovation and Reshape the Future of Health

SHANGHAI, March 18, 2022 /PRNewswire/ -- Recently, Johnson & Johnson announced that its medical devices business (Johnson & Johnson Medical Devices) will officially be renamed "Johnson & Johnson MedTech" globally. This new identity marks the transformation of Johnson & Johnson Medical into an innovative enterprise truly centered on patients and driven by business growth.

Ashley McEvoy, Global Executive Vice President of Johnson & Johnson and Global Chair of Johnson & Johnson MedTech, stated: "Our business is at a pivotal point of transition from medical devices to medical technology. As a medical technology enterprise with a wide global business presence, we are committed to continuously achieving groundbreaking scientific innovations and reimagining the future of human health in this era of accelerated digital transformation. The company’s new identity perfectly reflects the efforts we will make to realize this vision. In the future, we aim to become a leading global innovator in medical technology, bringing profound impact to the health of people worldwide."

As one of the most comprehensive healthcare companies with a wide range of business operations globally, Johnson & Johnson originated from the production of sterile surgical sutures and dressings. For over a century, Johnson & Johnson's medical business has been committed to advancing human health through innovation and technology. With continuous innovation and dedication, the company safeguards the health of patients and consumers worldwide, contributing wisdom and strength to the development of human health. Thanks to its robust innovation capabilities and outstanding achievements, Johnson & Johnson MedTech was honored on the "2022 Global Best Innovators Companies" list by Fast Company, one of the world’s most influential business magazines.

In recent years, with the continuous advancement of global medical technology, people's expectations for health have rapidly increased, and the demand for healthcare accessibility and digital solutions has become more urgent. Therefore, as a driving force and leader in the industry, the newly renamed Johnson & Johnson MedTech will continue to focus on the entire lifecycle of human healthcare -- from prevention to diagnosis, from treatment to rehabilitation. It will accelerate innovation, lead transformation, and better meet patients' current and future medical needs in more diverse and intelligent ways, helping them lead healthy and fulfilling lives.

Since entering the Chinese market in 1994, Johnson & Johnson's medical business has continuously expanded and refined its product lines and business layout. In fields such as surgery, orthopedics, cardiovascular, and specialized solutions, it has provided innovative products and professional services to healthcare professionals and patients, while actively promoting the healthy development of China’s healthcare industry. Currently, medical technology is Johnson & Johnson's largest business segment in China.Song Weiqun, Global Senior Vice President of Johnson & Johnson and Chairman of Johnson & Johnson China"Innovation and digital transformation are the core drivers of our high-quality development in China. Johnson & Johnson MedTech, together with all business segments, will continue to be guided by Our Credo, contributing to the health and well-being of 1.4 billion people in China and to China's economic development!"